Skip to main content

Table 3  A correlation between pathogenic germline mutations and risk of AML in analyzed patients

From: Germline mutations among Polish patients with acute myeloid leukemia

Gene Mutations Number of pathogenic germline mutations OR 95 % CI p-value
Tested group n = 103
[n/%]
Control group n = 103
[n/%]
CEBPA c.337_344del 1 0.97 % 0 0.00 % 3.03 0.122–75.235 p = 0.499
590_591insACCCGC 4 3,88 % 1 0.97 % 4.12 0.453–37.520 p = 0.209
ETV6 c.1075 C > T 1 0.97 % 0 0.00 % 3.03 0.122–75.235 p = 0.499
IDH2 c.419G > A 2 1.94 % 0 0.00 % 5.10 0.241-107.521 p = 0.295
All mutations   8 7.77 % 1 0.97 % 8.59 1.054–69.975 p = 0.046